Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imagion Biosystems.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
News
ASX Small Caps Lunch Wrap: Who spent $150k on a piece of violent hip-hop history today?
News
ASX Small Caps Lunch Wrap: Who else should try to lose some risk appetite today?
News
ASX Small Caps and IPO Weekly Wrap: 30 hours of hot ASX action and we’re right back where we started
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: The RBA’s interest rate lever pulling finally pays off, sending the ASX up 1.1%
News
ASX Small Caps and IPO Weekly Wrap: ASX falls 1.1% for the week, an ass-kicking we probably didn’t deserve
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Investors respond to the government’s Critical Minerals Strategy by selling everything in sight
News
In Case You Missed It: Biotech swoops in for the win today
News
ASX Small Caps Lunch Wrap: Who else has some terrible sins they need to confess today?
News
Top 10 at 10: Microcap biotech Imagion up 33pc after achieving enrolment target for Phase 1 trial
News
Market Highlights: Wall Street retreats, travel to boom again, and a new crypto exchange with a twist
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Not even the promise of top-shelf psychedelics could lift the market’s mood
News
ASX Small Caps Lunch Wrap: Who’s riding high on some psychedelic news this morning?
News